side effects from glp-1 medications Adverse of class drugs. Gastrointestinal issues are GLP-1 medications, commonly used for

According to the SURMOUNT-5 trial published in May 2025, participants on the maximum tolerated dose of Semaglutide (1.7 mg or 2.4 mg) achieved an average weight loss of 13.7% over 72 weeks

The methodology and endpoints of all studies reviewed are presented in Table S1

Additional therapies may include: NAD+ infusion therapy NAD+ injections Vitamin C infusion therapy Methylene blue infusion therapy Vitamin B12 injections Vitamin D3 injections Saline infusion therapy Red light therapy Ketamine infusion therapy Nutritional support and supplementation Our goal is to provide personalized, evidence-based wellness support focused on helping patients improve energy, recovery, cellular health, and overall quality of life

However, antidepressants are still sometimes prescribed to help if patients are experiencing depression (39)